USPTO Examiner HIRT ERIN E - Art Unit 1616

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19210210Herbicidal compositions comprising acetochlorMay 2025December 2025Allow710NoNo
19059897Herbicidal compositions comprising dimethenamidFebruary 2025September 2025Allow710YesNo
19054100Herbicidal compositions comprising imazethapyrFebruary 2025September 2025Allow720YesNo
18733167Aqueous Hop Extracts and Their Use as Antimicrobial AgentsJune 2024February 2026Allow2020NoNo
18633019Fungicidal CompositionApril 2024February 2026Allow2220YesNo
18608107Fungicidal CompositionsMarch 2024November 2025Abandon2010NoNo
18234250PROTOPORPHYRINOGEN OXIDASE INHIBITORSAugust 2023October 2025Allow2620YesNo
18355800PROTOPORPHYRINOGEN OXIDASE INHIBITORSJuly 2023September 2023Allow200NoNo
18255167HERBICIDAL DERIVATIVESMay 2023January 2026Allow3210YesNo
18122583PROTOPORPHYRINOGEN OXIDASE INHIBITORSMarch 2023June 2023Allow300YesNo
18041293HERBICIDAL COMPOSITIONSFebruary 2023March 2026Abandon3720NoNo
17905446AZOLE DERIVATIVE, METHOD FOR PRODUCING AZOLE DERIVATIVE, AGENT FOR AGRICULTURAL AND HORTICULTURAL USE, AND INDUSTRIAL MATERIAL PROTECTION AGENTFebruary 2023February 2024Abandon1820YesNo
18158077Aqueous Hop Extracts and Their Use as Antimicrobial AgentsJanuary 2023May 2024Allow1630YesNo
18156306NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLYJanuary 2023September 2025Allow3220YesNo
18014948HERBICIDAL HETEROCYCLIC DERIVATIVESJanuary 2023February 2026Abandon3701NoNo
18091476PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOFDecember 2022April 2025Allow2820YesNo
18003745SUBSTITUTED HETEROARYLOXYPYRIDINES, THE SALTS THEREOF AND THEIR USE AS HERBICIDAL AGENTSDecember 2022November 2025Abandon3510NoNo
18008054METHOD FOR REDUCING OR PREVENTING EFFECT OF NON-BIOLOGICAL STRESS ON PLANTDecember 2022November 2025Abandon3610NoNo
17999249HERBICIDAL CINNOLINE DERIVATIVESNovember 2022February 2026Allow3820NoYes
17922953RODENTICIDAL BAIT AND METHOD OF CONTROLLING TARGET HARMFUL RODENTSNovember 2022December 2025Abandon3711NoNo
18046822SUBSTITUTED THIOPHENYL URACILS, SALTS THEREOF AND THE USE THEREOF AS HERBICIDAL AGENTSOctober 2022October 2023Allow1220YesNo
17965703SYNERGISTIC EFFECT OF ISOXABEN AND CELLULOSIN AS AN HERBICIDEOctober 2022August 2023Allow1010YesNo
17802298HERBICIDAL MALONAMIDESAugust 2022March 2025Allow3000YesNo
17855072ANTISEPTIC, ANTISEBORRHEIC, EXFOLIATING COMPOSITION TO REMOVE OR PREVENT ACNEJune 2022May 2024Allow2220YesNo
17843188TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOFJune 2022August 2023Abandon1410NoNo
17775766FUNGICIDAL COMBINATIONSMay 2022February 2026Abandon4521NoNo
17739667WEED CONTROL AND FERTILIZERMay 2022December 2023Allow2011YesNo
17737071MOLECULE HAVING PESTICIDAL UTILITY, AND COMPOSITIONS, AND PROCESSES, RELATED THERETOMay 2022February 2023Allow920YesNo
17728090HAIR COSMETIC COMPOSITION CONTAINING AQUEOUS GELLING AGENT, AND METHOD FOR PRODUCING AQUEOUS GELLING AGENT AND HAIR COSMETIC COMPOSITIONApril 2022March 2024Abandon2321NoNo
17724814PERCUTANEOUS ANTI-MICROBIOTA FORMULATIONSApril 2022May 2024Abandon2521NoNo
17770136HERBICIDAL GLUFOSINATE COMPOSITIONApril 2022December 2025Abandon4420NoNo
17769548TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF FINGOLIMODApril 2022December 2025Abandon4421NoNo
17691207METHOD FOR CONTROLLING THE GROWTH OF UNDESIRABLE VEGETATIONMarch 2022August 2024Abandon3021YesNo
17691346METHOD FOR CONTROLLING THE GROWTH OF UNDESIRABLE VEGETATIONMarch 2022April 2024Abandon2611NoNo
17691217METHOD FOR CONTROLLING THE GROWTH OF UNDESIRABLE VEGETATIONMarch 2022August 2024Abandon3021NoNo
17691343METHOD FOR CONTROLLING THE GROWTH OF UNDESIRABLE VEGETATIONMarch 2022October 2024Abandon3121NoNo
17654131INHALED POWDER FORMULATIONSMarch 2022January 2024Abandon2220NoNo
17686125COMPOSITIONS, METHODS, AND SYSTEMS FOR CONTROLLING INVASIVE MUSSEL SPECIESMarch 2022January 2024Abandon2311NoNo
17674398MICRONUTRIENT-ENHANCED POLYMERIC SEED COATINGSFebruary 2022May 2023Allow1510YesNo
17592641SILVER ANTIMICROBIALSFebruary 2022February 2023Allow1220YesNo
17560453TAURULTAM, TAURINAMIDE AND METHYLENE GLYCOL TREATMENT FOR MYC-EXPRESSING TUMORS IN MAMMALIAN BODIESDecember 2021March 2024Allow2711YesNo
17595084HIGH SPREADING ULV FORMULATIONS FOR AGROCHEMICAL COMPOUNDS IINovember 2021January 2026Abandon5020NoNo
17499691NEMATODE DETERRENT COMPOSITIONSOctober 2021January 2024Abandon2720NoNo
17488083ARYLAZOLE COMPOUND AND PEST CONTROL AGENTSeptember 2021September 2023Allow2420YesNo
17394079SPRAYABLE POLYMERS AS ADHESION BARRIERSAugust 2021October 2023Abandon2610NoNo
17381665Fungicidal CompositionJuly 2021February 2024Allow3020YesNo
17342754MIXTURE OF MECTINS AND PYRETHROIDS AND USES THEREOFJune 2021March 2024Allow3431YesNo
17331248COMBINATION COMPRISING A BENZAMIDE HERBICIDE AND A PYRIDINE CARBOXYLIC ACID HERBICIDE, AND A METHOD FOR MAKING AND USING THE COMBINATIONMay 2021September 2024Abandon4021NoNo
17330209LIPOSOMAL APPARATUS AND MANUFACTURING METHODSMay 2021February 2022Allow910YesNo
17329755LIPOSOMAL APPARATUS AND MANUFACTURING METHODSMay 2021March 2022Allow1020YesNo
17239434MICROALGAE BASED COMPOSITIONS AND METHODS FOR APPLICATION TO PLANTSApril 2021November 2024Abandon4330YesNo
17285178USE OF COMPOSITION AS A GROWTH PROMOTANT FOR PLANTSApril 2021March 2024Allow3510YesNo
17283293PESTICIDAL COMPOUNDSApril 2021May 2025Allow4911YesNo
17282018TRICYCLIC PESTICIDAL COMPOUNDSApril 2021June 2024Allow3910YesNo
17279278PESTICIDALLY ACTIVE CYCLOPROPYL METHYL AMIDE DERIVATIVESMarch 2021November 2023Abandon3110NoNo
17203220LIPOSOMAL APPARATUS AND MANUFACTURING METHODSMarch 2021October 2023Abandon3111NoNo
17276064ISOXAZOLINE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTSMarch 2021May 2024Abandon3810NoNo
17181437GLYPHOSATE FORMULATIONS CONTAINING AMIDOALKYLAMINE SURFACTANTSFebruary 2021November 2023Allow3220YesNo
17269669EXTENDED AND CONTINUOUS RELEASE COMPOSITIONS FOR PLANT HEALTH AND METHOD OF USEFebruary 2021May 2024Abandon3911NoNo
17266208PESTICIDALLY-ACTIVE BICYCLIC HETEROAROMATIC COMPOUNDSFebruary 2021June 2024Abandon4010NoNo
17263053Crystalline Form of FluopyramJanuary 2021May 2024Abandon4020NoNo
17262056ISOXAZOLIN-5-ONE DERIVATIVES AND HERBICIDES CONTAINING THE SAME AS ACTIVE INGREDIENTSJanuary 2021March 2024Abandon3810NoNo
17258752Preparation Method of Pyrimidinylthio-benzoate Oxime Ester Compound and Application thereof as HerbicideJanuary 2021September 2023Allow3210YesNo
17257187URACIL COMPOUND AND USE THEREOFDecember 2020July 2023Allow3010NoNo
17256397SYNERGISTICALLY EFFECTIVE HERBICIDE COMPOSITION COMPRISING METOBROMURON AND CLOMAZONEDecember 2020June 2024Allow4230YesNo
17126274METHOD OF TREATING FIBROSISDecember 2020April 2024Allow4031YesNo
17123584AGRICULTURAL COMPOSITIONS AND METHODS OF USE THEREOFDecember 2020January 2024Abandon3721NoNo
17250208HERBICIDAL FORMULATIONS COMPRISING GLYPHOSATE AND COTE-BASED ADJUVANTSDecember 2020January 2024Allow3710YesNo
16973292COMPOSITIONS CONTAINING MICROENCAPSULATED ORGANIC COMPOUNDSDecember 2020December 2025Abandon6041YesNo
17113206MOLECULE HAVING PESTICIDAL UTILITY, AND COMPOSITIONS, AND PROCESSES, RELATED THERETODecember 2020March 2023Allow2720YesNo
17055512LUNG SURFACTANT-BASED ANTICANCER DRUGNovember 2020March 2024Abandon4010NoNo
17053348cis-p-Menthane-1,8-Di-secondary Amine Compounds as well as Their Preparation Methods and Application in Weed ControlNovember 2020August 2024Abandon4521NoNo
17063458ANTISEPTIC, ANTISEBORRHEIC AND EXFOLIATING COMPOSITION TO REMOVE OR PREVENT ACNEOctober 2020October 2022Abandon2410NoNo
17061134Preparation Method of Antibacterial Deodorizing Modified Fiber for Water PurificationOctober 2020May 2023Allow3210YesNo
17043969HERBICIDAL COMPOUNDSSeptember 2020August 2022Abandon2310NoNo
17039232NOVEL-ALKYNYL-SUBSTITUTED 3-PHENYLPYRROLIDINE-2,4-DIONES AND USE THEREOF AS HERBICIDESSeptember 2020February 2024Abandon4010NoNo
17042005FUNGICIDAL FERTILIZER COMPOSITION COMPRISING POTASSIUM PHOSPHITE AND GAMMA-POLY-GLUTAMIC ACIDSeptember 2020October 2024Abandon4820NoNo
16980603Herbicide FormulationSeptember 2020October 2024Abandon4920NoNo
16978922HERBICIDAL COMPOUNDSSeptember 2020March 2024Allow4210YesNo
16977071SEED, SOIL, AND PLANT TREATMENT COMPOSITIONS INCLUDING YEAST EXTRACTAugust 2020April 2022Abandon1910NoNo
16968555MALEIMIDE DERIVATIVES HAVING HERBICIDAL ACTIVITY, AGRONOMIC COMPOSITIONS OF THE MALEIMIDE DERIVATIVES, AND USES THEREOFAugust 2020December 2023Allow4011YesNo
16929420UNSATURATED FATTY ALCOHOL DERIVATIVES FROM NATURAL OIL METATHESISJuly 2020May 2023Allow3420YesNo
16927355METHOD OF SUSPENDING WEED GROWTH IN SOILJuly 2020February 2024Abandon4310NoNo
16922799FRUITY ODORANTJuly 2020February 2022Allow1910YesNo
16955809FLUORALKENYL COMPOUNDS, PROCESS FOR PREPARATION AND USE THEREOFJune 2020October 2022Abandon2811NoNo
16955554SUBSTITUTED THIOPHENYL URACILS, SALTS THEREOF AND THE USE THEREOF AS HERBICIDAL AGENTSJune 2020July 2022Allow2531NoNo
16900140PRAMIPEXOLE TRANSDERMAL DELIVERY SYSTEM AND USES THEREOFJune 2020December 2021Allow1820YesNo
16875855DPI FORMULATION CONTAINING SULFOALKYL ETHER CYCLODEXTRINMay 2020February 2022Allow2120YesNo
16764157PROCESS FOR THE PREPARATION OF ALKOXYLATES COMPOSITIONSMay 2020September 2023Abandon4021NoNo
16842480PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOFApril 2020November 2021Allow1910YesNo
16754050Pesticidally Active Pyrrole DerivativesApril 2020May 2022Allow2610YesNo
16754016Pesticidally Active Pyrrole DerivativesApril 2020March 2022Allow2310YesNo
16649626Herbicidally Active Pyridyl-/Pyrimidyl-Pyrimidine DerivativesMarch 2020March 2024Abandon4831NoNo
16823523ELECTROLYTE PURGATIVEMarch 2020November 2023Abandon4421NoNo
16644349FUNGICIDE COMPOSITION AND METHOD FOR CONTROLLING DISEASE OF CROPMarch 2020January 2023Allow3430YesNo
16639723HERBICIDAL COMPOUNDSFebruary 2020November 2022Allow3310YesNo
16638884HERBICIDALLY ACTIVE 3-PHENYL-5-TRIFLUOROMETHYLISOXAZOLINE-5-CARBOXAMIDES OF CYCLOPENTYLCARBOXYLIC ACIDS AND ESTERSFebruary 2020April 2022Abandon2610NoNo
16638726LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONSFebruary 2020April 2024Allow5031YesNo
16636698USE OF A NON-IONIC SURFACTANT WHICH IS A POLYOL DERIVATIVE AS A PLANT GROWTH STIMULATING AGENT OR AS AN ADJUVANTFebruary 2020January 2024Abandon4741YesNo
16776876TREATING TURFGRASS FOR FUNGAL DISEASEJanuary 2020February 2023Abandon3620NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HIRT, ERIN E.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
35
Examiner Affirmed
28
(80.0%)
Examiner Reversed
7
(20.0%)
Reversal Percentile
30.9%
Lower than average

What This Means

With a 20.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
88
Allowed After Appeal Filing
18
(20.5%)
Not Allowed After Appeal Filing
70
(79.5%)
Filing Benefit Percentile
26.8%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 20.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner HIRT, ERIN E - Prosecution Strategy Guide

Executive Summary

Examiner HIRT, ERIN E works in Art Unit 1616 and has examined 671 patent applications in our dataset. With an allowance rate of 40.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 35 months.

Allowance Patterns

Examiner HIRT, ERIN E's allowance rate of 40.1% places them in the 7% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by HIRT, ERIN E receive 2.71 office actions before reaching final disposition. This places the examiner in the 79% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by HIRT, ERIN E is 35 months. This places the examiner in the 38% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +17.7% benefit to allowance rate for applications examined by HIRT, ERIN E. This interview benefit is in the 59% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 12.9% of applications are subsequently allowed. This success rate is in the 8% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 23.8% of cases where such amendments are filed. This entry rate is in the 32% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 50.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 42% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 47.8% of appeals filed. This is in the 13% percentile among all examiners. Of these withdrawals, 37.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 81.9% are granted (fully or in part). This grant rate is in the 85% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 0% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.7% of allowed cases (in the 58% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.